This RNF181/circRNA-SFMBT2/ERα ternary complex reduced ubiquitination-mediated ERα degradation and activated ERα signaling to facilitate cell growth and tamoxifen resistance in breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.